FindTrial
Sign In

Study of tumor imaging by positron emission tomography agent 68Ga-SGC8

Study of tumor imaging by positron emission tomography agent aptamer 68Ga-SGC8

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16010114
Enrollment
Unknown
Registered
2016-12-08
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor

Interventions

Gold Standard:
Index test:

Sponsors

First Affiliated Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with primary or metastatic solid tumors

Exclusion criteria

Exclusion criteria: No operation plan (without Pathology results), under the age of 18, pregnant, lactating, serious hepatic and renal function insufficiency (alanine aminotransferase 8-10 times above the upper limit of normal value, serum creatinine 186-442umol/L).

Design outcomes

Primary

MeasureTime frame
SUV (standard uptake value);—

Countries

China

Contacts

Public ContactWang Jing

First Affiliated Hospital, Fourth Military Medical University

wangjing@fmmu.edu.cn+86 13909245902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026